Polskie Radio explains how to check when the FDA approved Zepbound

More peptides

1. Dr Terry Simpson on hitting protein targets when a GLP-1 cuts your appetite

   

   DTDr. Terry Simpson, MD, FACS Oct 19

   peptides typeshitNews

   Dr Terry Simpson on hitting protein targets when a GLP-1 cuts your appetite

   The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.

   Watch on TikTok
2. A look at whether the munchies feel different for people on a GLP-1

   

   FFacebook Oct 19

   peptides typeshitNews

   A look at whether the munchies feel different for people on a GLP-1

   A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.

   See it on Facebook
3. Washington Post opinion writer calls GLP-1s the miracle drugs of a generation

   

   P@postopinions Oct 19

   peptides typeshitNews

   Washington Post opinion writer calls GLP-1s the miracle drugs of a generation

   The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.

   See it on Instagram
4. 63 & Counting on going from 270 to 222 pounds on tirzepatide in six months

   11:37

   6C63 & Counting Oct 19

   peptides typeshitNews

   63 & Counting on going from 270 to 222 pounds on tirzepatide in six months

   A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.

   Watch on YouTube
5. Peptide patients paying up to $1,500 a month run into an FDA problem

   TTheStreet Oct 10

   peptides typeshitLegal

   Peptide patients paying up to $1,500 a month run into an FDA problem

   TheStreet looks at people spending heavily on peptides each month and the regulatory trouble now facing what they buy.

   Read at TheStreet
6. Mayo Clinic on when to stop a GLP-1 and how to avoid regaining weight

   

   M@mayoclinic Oct 10

   peptides typeshitResearch

   Mayo Clinic on when to stop a GLP-1 and how to avoid regaining weight

   With about 11% of the US on a GLP-1 for weight loss, Mayo Clinic tackles how much loss is enough and what helps keep the weight off.

   See it on Instagram